TrialNeuropsychopharmacology reports2020

A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects.

James Ermer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.